During the past decade, East Bay Retina Consultants, Inc. conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Bay Retina Consultants, Inc." #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Jaeb Center for Health Research" with 6 trials sponsored, "Allergan" with 1 trials sponsored, "Carl Zeiss Meditec, Inc." with 1 trials sponsored and "Clearside Biomedical, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East Bay Retina Consultants, Inc." #1 collaborator was "National Eye Institute (NEI)" with 6 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 5 trials as a collaborator, "National Institutes of Health (NIH)" with 5 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "East Bay Retina Consultants, Inc." are "Diabetic Macular Edema" (8 trials), "Geographic Atrophy" (4 trials), "Central Retinal Vein Occlusion" (2 trials), "Macular Edema" (2 trials) and "Age Related Macular Degeneration" (1 trials). Many other conditions were trialed in "East Bay Retina Consultants, Inc." in a lesser frequency.

Most popular intervention types in "East Bay Retina Consultants, Inc." are "Drug" (13 trials), "Other" (5 trials), "Procedure" (5 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (4 trials), "Faricimab" (3 trials), "Aflibercept" (2 trials), "Lampalizumab" (2 trials) and "Ranibizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "East Bay Retina Consultants, Inc." are 19 trials for "All" genders.

Currently, there are NaN active trials in "East Bay Retina Consultants, Inc.". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in East Bay Retina Consultants, Inc., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in East Bay Retina Consultants, Inc., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".